Resting State Functional Magnetic Resonance Imaging Study of Jaundice Infants Before and After Light Treatment.
NCT ID: NCT02224586
Last Updated: 2014-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2014-08-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigates assume that the children with jaundice after light therapy, ALFF and CBF will change. Focus on the globus pallidus and subthalamic nuclei. The two brain regions were proved to be abnormal in MRI T1, T2 structure signal in kernicterus.
Doctors observe the status of infants aside.Using monitoring probe can see clearly.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A MRI Study of Visual and Motor Pathways in Premature Infants
NCT01514747
MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates
NCT02637817
Magnetic Resonance Biomarkers in Neonatal Encephalopathy
NCT01309711
Use of 3D/4D Ultrasound in the Evaluation of Fetal Anomalies
NCT00826917
3D Craniofacial Morphologic Development of Healthy Infants
NCT05004597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
light treatment
clinical routine treatment according to the doctor's advice
light treatment
clinical routine treatment according to the doctor's advice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
light treatment
clinical routine treatment according to the doctor's advice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cerebral dysgenesis
1 Day
28 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hangzhou Normal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-Fei Zhu
chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ya-Fei Zhu
Role: PRINCIPAL_INVESTIGATOR
Center for Cognition and Brain Disorders,Hangzhou Normal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Cognition and Brain Disorders
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HNU_AH_jaundice fMRI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.